Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
ProBioGen AG
ProBioGen AG
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
ProBioGen and DIOSynVax partner to manufacture multivalent vaccine for hemorrhagic fever
The novel vaccine targets HF diseases caused by Ebola, Marburg, and Lassa viruses
Regulatory
ProBioGen granted new patent for DirectedLuck transposase technology
ProBioGen announces that the Japan Patent Office (JPO) issued the first patent for the company’s DirectedLuck technology
Drug Delivery
ProBioGen and ImmunOs Therapeutics team up on therapy for cancer patients
ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic
Manufacturing
ProBioGen enters technology collaboration with Boehringer Ingelheim
It contributes to Boehringer Ingelheim's goal of using cutting-edge technologies across the whole biopharmaceutical value chain
Manufacturing
ProBioGen and Thermo Fisher Scientific team up on cell platform
The new kit uses Thermo Fisher's ExpiCHO-S cell line and a new powerful media platform specifically developed for it
Manufacturing
ProBioGen and City of Hope announce commercial licence for manufacturing
The agreement will allow City of Hope to manufacture its MVA-based CMV vaccine using ProBioGen’s platform
Manufacturing
ProBioGen chooses NextPoint for GMP manufacturing of antibody
NextPoint has been selected to fast track CMC development and manufacturing of this unique antibody that targets a novel immune checkpoint axis offering promise for hard-to-treat cancers
Subscribe now